Does Dr. DOUGLAS ADKINS have financial conflicts of interest?

Dr. DOUGLAS ADKINS (MD) has received a total of $98,294 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $89,621 in personal promotional payouts (consulting, meals, travel) and $8,673 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. DOUGLAS ADKINS?

According to CMS Open Payments data, Dr. DOUGLAS ADKINS received funding from COHERUS BIOSCIENCES ($14,308), MERCK SHARP & DOHME ($12,655), and EISAI ($11,672).

Does Dr. DOUGLAS ADKINS receive research grants or speaking fees?

Dr. DOUGLAS ADKINS has received $89,621 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $8,673 in clinical research grants.

DR. DOUGLAS ADKINS

MDReal-Time Hydrated

Specialty: Internal Medicine, Medical Oncology

Practice Location: SAINT LOUIS, MO 63108

NPI Number: 1164440616

LIFETIME INDUSTRY VALUE

$98,294

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ADKINS is a verified Internal Medicine, Medical Oncology practitioner based in SAINT LOUIS, MO.

Between 2021 and 2024, Dr. ADKINS had an overall industry promotional and research financial footprint of $98,294 as recorded in the federal CMS Open Payments database.

$89,621 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$8,673 was allocated to sponsored clinical trials and medical research activities.

Dr. ADKINS's primary funding source is COHERUS BIOSCIENCES, which accounts for $14,308 (representing 14.6% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

COHERUS BIOSCIENCES

Rank 1

$14,308

14.6%

MERCK SHARP & DOHME

Rank 2

$12,655

12.9%

EISAI

Rank 3

$11,672

11.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.